Abstract
Suicide and suicidal behaviour are a major health concern worldwide particularly in patients with mood disorders. Family, adoption and twin studies show that genetics influences suicidal behaviour. The serotonin transporter (5HTT) plays an important role in the pathophysiology of mood disorders and may also be involved in suicidal behaviour since 5HTT binding is decreased in the brain of suicide completers. Because the effect of genomic imprinting in the 5HTT gene on suicidal behaviour has not been investigated, we analysed the parent-of-origin effect (POE) of four 5HTT markers and the differential expression of the 5HTT G2651T (rs1042173) alleles in suicide attempters affected by bipolar disorder. We performed a family based association study and ETDT/QTDT analyses of the rs25531, HTTLPR, VNTR-2 and G2651T polymorphisms in 312 nuclear families with at least one subject affected by bipolar disorder. The main outcomes investigated in this study are bipolar disorder diagnosis, suicide attempts, suicidal behaviour severity and age at onset of bipolar disorder. We also compared the allele-specific mRNA levels in lymphoblastoid cells from 13 bipolar suicide attempters and 8 bipolar non-suicide attempters. Allele 2651T was transmitted significantly more often to bipolar patients (P = 0.042). There was no significant difference between maternal and paternal transmission ratios. Furthermore, there was no significant difference in the ratio of T/G-specific mRNA expression between bipolar attempters and non-attempters. These data do not support a role for differential allelic expression of 5HTT for suicidal behaviour in bipolar disorder. Small sample size and the fact that RNA was obtained from lymphoblastoid cell lines were some of the limitations of this study.
Similar content being viewed by others
References
Anguelova M, Benkelfat C, Turecki G (2003) A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I affective disorders. Mol Psychiatry 8:574–591
Altamura AC, Dell’Osso B, Berlin HA, Buoli M, Bassetti R, Mundo E (2010) Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci 260:385–391
Caspi A, Sugden K, Moffitt TE et al (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389
Chen YW, Dilsaver SC (1996) Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol Psychiatry 39:896–899
Cho HJ, Meira-Lima I, Cordeiro Q et al (2005) Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. Mol Psychiatry 10:771–781
Contreras J, Hare L, Camarena B et al (2009) The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr Scand 119:117–127
Hegerl U, Mergl R, Havers I, Schmidtke A, Lehfeld H, Niklewski G, Althaus D (2010) Sustainable effects on suicidality were found for the Nuremberg alliance against depression. Eur Arch Psychiatry Clin Neurosci 260:401–406
Kato T, Winokur G, Coryell W et al (1996) Parent-of-origin effect in transmission of bipolar disorder. Am J Med Genet 67:546–550
Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B (2005) The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry 62:529–535
Goodwin FK, Jaminson KR (1990) Manic depressive illness. Oxford University Press, New York
Li D, He L (2007) Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behaviour. Mol Psychiatry 12:47–54
Lim JE, Papp A, Pinsonneault J, Sadee W, Saffen D (2006) Allelic expression of serotonin transporter (SERT) mRNA in human pons: lack of correlation with the polymorphism SERTLPR. Mol Psychiatry 11:649–662
Lonnqvist JK, Henriksson MM, Isometsa ET, Marttunen MJ, Heikkinen ME, Aro HM, Kuoppasalmi KI (1995) Mental disorders and suicide prevention. Psychiatry Clin Neurosci 49(Suppl 1):S111–S116
Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H (1994) Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287–290
Lucki I (1998) The spectrum of behaviours influenced by serotonin. Biol Psychiatry 44:151–162
Müller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL (2006) Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. Br J Psychiatry 189:317–323
Neumaier JF, Root DC, Hamblin MW (1996) Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal Raphe nucleus. Neuropsychopharmacology 15:515–522
Risch N, Herrell R, Lehner T et al (2009) Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301:2462–2471
Schloss P, Williams DC (1998) The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 12:115–121
Schulze TG, Muller DJ, Krauss H et al (2002) Further evidence for age of onset being an indicator for severity in bipolar disorder. J Affect Disord 68:343–345
Acknowledgments
National Alliance for Research on Schizophrenia and Depression (Young Investigator to VDL), American Foundation for Suicide Prevention (Pilot Gant to VDL) and Canadian Institutes of Health Research (Fellowship #93967 to RPS and Clinician-Scientist Phase II fellowship to AHCW).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
A. Wong and V. De Luca have contributed equally to the preparation of this manuscript.
Rights and permissions
About this article
Cite this article
Pinto, C., Souza, R.P., Lioult, D. et al. Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour. Eur Arch Psychiatry Clin Neurosci 261, 533–538 (2011). https://doi.org/10.1007/s00406-011-0192-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00406-011-0192-8